Hsbc Holdings PLC Sells 6,090 Shares of Innophos Holdings, Inc. (IPHS)

Share on StockTwits

Hsbc Holdings PLC trimmed its holdings in Innophos Holdings, Inc. (NASDAQ:IPHS) by 12.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 43,751 shares of the specialty chemicals company’s stock after selling 6,090 shares during the quarter. Hsbc Holdings PLC owned approximately 0.22% of Innophos worth $1,759,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in IPHS. Neuberger Berman Group LLC increased its holdings in shares of Innophos by 495.2% in the 1st quarter. Neuberger Berman Group LLC now owns 532,920 shares of the specialty chemicals company’s stock valued at $21,429,000 after acquiring an additional 443,390 shares during the period. Segall Bryant & Hamill LLC increased its holdings in shares of Innophos by 20.0% in the 4th quarter. Segall Bryant & Hamill LLC now owns 984,342 shares of the specialty chemicals company’s stock valued at $45,998,000 after acquiring an additional 163,824 shares during the period. Wells Fargo & Company MN increased its holdings in shares of Innophos by 353.9% in the 1st quarter. Wells Fargo & Company MN now owns 181,880 shares of the specialty chemicals company’s stock valued at $7,313,000 after acquiring an additional 141,808 shares during the period. Millennium Management LLC increased its holdings in shares of Innophos by 184.6% in the 4th quarter. Millennium Management LLC now owns 204,174 shares of the specialty chemicals company’s stock valued at $9,541,000 after acquiring an additional 132,421 shares during the period. Finally, Fort Washington Investment Advisors Inc. OH increased its holdings in shares of Innophos by 32.9% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 357,100 shares of the specialty chemicals company’s stock valued at $14,359,000 after acquiring an additional 88,400 shares during the period. 95.27% of the stock is currently owned by institutional investors and hedge funds.

Shares of Innophos opened at $48.67 on Wednesday, according to Marketbeat.com. The company has a debt-to-equity ratio of 1.03, a quick ratio of 1.70 and a current ratio of 3.22. The firm has a market capitalization of $959.44 million, a price-to-earnings ratio of 19.78 and a beta of 0.83. Innophos Holdings, Inc. has a 1 year low of $38.66 and a 1 year high of $51.34.

Innophos (NASDAQ:IPHS) last announced its quarterly earnings data on Tuesday, May 1st. The specialty chemicals company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.55 by $0.06. The company had revenue of $205.00 million for the quarter, compared to analysts’ expectations of $196.91 million. Innophos had a net margin of 2.95% and a return on equity of 14.26%. Innophos’s revenue was up 23.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.59 EPS. equities research analysts expect that Innophos Holdings, Inc. will post 2.7 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 5th. Shareholders of record on Friday, May 18th were paid a $0.48 dividend. The ex-dividend date was Thursday, May 17th. This represents a $1.92 annualized dividend and a yield of 3.94%. Innophos’s dividend payout ratio is currently 78.05%.

A number of brokerages have recently commented on IPHS. BidaskClub raised shares of Innophos from a “strong sell” rating to a “sell” rating in a report on Tuesday, April 24th. TheStreet cut shares of Innophos from a “b-” rating to a “c” rating in a report on Wednesday, February 21st. Finally, Zacks Investment Research raised shares of Innophos from a “sell” rating to a “hold” rating in a report on Wednesday, April 25th.

Innophos Company Profile

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Insider Buying: Synovus Financial Corp.  Director Buys $250,000.00 in Stock
Insider Buying: Synovus Financial Corp. Director Buys $250,000.00 in Stock
Evergy  Price Target Increased to $57.00 by Analysts at UBS Group
Evergy Price Target Increased to $57.00 by Analysts at UBS Group
Leggett & Platt  Raised to Hold at Zacks Investment Research
Leggett & Platt Raised to Hold at Zacks Investment Research
PRGX Global  Stock Rating Lowered by ValuEngine
PRGX Global Stock Rating Lowered by ValuEngine
Fidelity Southern  Upgraded to Buy by ValuEngine
Fidelity Southern Upgraded to Buy by ValuEngine
Hi-Crush Partners  Upgraded to Hold by ValuEngine
Hi-Crush Partners Upgraded to Hold by ValuEngine


Leave a Reply

 
© 2006-2018 Zolmax.